No Data
With A Return On Equity Of 18%, Has Puma Biotechnology, Inc.'s (NASDAQ:PBYI) Management Done Well?
PUMA Explores Leather Vs Vegan Leather With Global Goals Ambassador
12 Health Care Stocks Moving In Tuesday's After-Market Session
PUMA Appoints Markus Neubrand as Chief Financial Officer
PUMA Transforms Product Campaign Development With Google Cloud's Generative AI
Puma Biotechnology (NASDAQ:PBYI) Investors Are Sitting on a Loss of 79% If They Invested Five Years Ago